Immediate Release Dissolution Testing
Immediate Release Dissolution Testing is a standardized in vitro pharmaceutical testing method that characterizes the rate and extent of drug release from immediate release dosage forms under controlled conditions, differentiating it from modified release formulations by its focus on rapid disintegration and dissolution within a short timeframe.
69
Publications
2.6K
Citations
308
Authors
111
Institutions
Publications per year
2017–2026
24
Parents
69
1–5 of 69
308
5
h-index
4
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
4 publications · 196 citations
4
h-index
3
h-index
Agencia Española de Medicamentos y Productos Sanitarios, Spain
3 publications · 69 citations
3
h-index
1–5 of 308
111
Center for Drug Evaluation and Research
Silver Spring, United States
8 h-index
36 publications
3.8K citations
United States Food and Drug Administration
Silver Spring, United States
8 h-index
26 publications
1.4K citations
Pfizer (United States)
New York, United States
5 h-index
12 publications
1.1K citations
Eli Lilly (United States)
Indianapolis, United States
5 h-index
8 publications
1.3K citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
4 h-index
6 publications
139 citations
Goethe University Frankfurt
Frankfurt am Main, Germany
4 h-index
8 publications
1.3K citations
AbbVie (United States)
North Chicago, United States
4 h-index
8 publications
395 citations

Universitat de Miguel Hernández d'Elx
Elche, Spain
3 h-index
6 publications
190 citations
1–8 of 111
13 publications · 497 citations
11
h-index
8 publications · 631 citations
8
h-index
5 publications · 260 citations
6
h-index
3 publications · 110 citations
4
h-index
4 publications · 114 citations
4
h-index
1–5